Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Companies(42)
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Cytel
Cytel is a clinical research organization specializing in advanced analytics, data science, and software solutions for pharmaceutical and biotech companies. The company provides end-to-end support across the drug development lifecycle from discovery through commercialization.
Deep 6 AI
Deep 6 AI provides an artificial intelligence platform that accelerates patient recruitment for clinical trials by analyzing electronic health records in real-time. The company helps healthcare organizations and research institutions identify eligible patients faster and more accurately.
Faro Health
Faro Health appears to be a health AI company focused on clinical trials and research, though specific details about their products and services are not available from the scraped content.
Formation Bio
Formation Bio is a technology-driven pharmaceutical company that develops drugs and builds AI-powered software to accelerate clinical trials and drug development.
Grove AI
Grove AI provides agentic AI solutions for clinical trial operations, featuring Grace, their Digital Staff agent that automates participant recruitment, prescreening, and engagement. The platform serves site networks, CROs, and pharmaceutical sponsors to accelerate enrollment and reduce operational burden.
Inato
Inato is an AI-powered clinical trial platform that connects sponsors, research sites, and patients to accelerate enrollment and expand access to clinical research. The platform enables sponsors to identify high-performing sites and helps research sites win trial opportunities while reducing operational burden.
IQVIA
IQVIA empowers life sciences organizations to accelerate innovation and improve patient outcomes through advanced analytics, technology, and clinical research services.
Iterative Health
Iterative Health operates a global clinical trial site network specializing in GI, Hepatology, Obesity, and Cardiology research. The company connects sponsors and CROs with high-performing community-based research sites, accelerating patient enrollment and trial timelines through operational support and AI-powered technology.
Lindus Health
Lindus Health is a next-generation contract research organization (CRO) that delivers integrated clinical trial execution through an AI-assisted operating system. The company provides end-to-end trial delivery with milestone-based commercial terms, combining patient recruitment, site management, and clinical operations into one accountable platform.
Lokavant
Lokavant provides AI-powered clinical trial intelligence and optimization solutions for pharmaceutical and biotech companies to accelerate drug development and improve trial execution.
Massive Bio
Massive Bio operates an AI-powered platform that connects cancer patients with clinical trials worldwide. The company matches patients to over 19,000 active oncology and hematology trials by analyzing 500+ medical data elements, serving 200,000+ onboarded patients across multiple countries.
Medable
Medable is a clinical trial technology platform that uses agentic AI to accelerate clinical development. The company provides eCOA, eConsent, and AI agents that automate trial workflows, reduce manual burden, and enable sponsors, CROs, and research sites to build studies faster and conduct trials more efficiently.
Medidata
Medidata powers smarter clinical trials with unified data, AI-driven insights, and patient-centric technology to accelerate research.
Neosoma
Neosoma provides AI-powered brain tumor analysis software for neuro-oncology teams. The platform automates lesion mapping, measurement, tracking, and contouring across MRI timepoints for gliomas and brain metastases, delivering clinical decision support and workflow efficiencies.
nference
nference is an AI platform company that partners with healthcare centers to transform electronic medical records and multimodal clinical data into actionable insights for drug development, clinical research, and precision medicine.
ObvioHealth
ObvioHealth provides an end-to-end digital clinical trial platform that simplifies study design, accelerates participant recruitment, and delivers real-time data capture. The ObvioGo platform enables decentralized and hybrid trials for CROs, pharma, biotech, medical device companies, and consumer health organizations.
Paradigm
Paradigm Health is re-engineering clinical research by embedding AI-native technology directly into provider workflows. The platform connects trial sponsors with a network of 100+ research sites to optimize protocols, accelerate patient enrollment, and automate data collection.
Parexel
Parexel is a global contract research organization (CRO) providing end-to-end biopharmaceutical services from early phase clinical trials through regulatory approval and market access. The company serves pharmaceutical, biotech, and medical device companies with integrated clinical development solutions.
PhaseV
PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions. The platform optimizes trial design, identifies patient subgroups, and enhances clinical operations to reduce costs and accelerate drug development.
Phesi
Phesi provides AI-powered clinical trial optimization solutions for life sciences companies. Using the world's largest clinical trials database with real-world data from 325+ million patients, Phesi enables protocol design optimization, digital twins, and investigator site selection to accelerate drug development.
QuantHealth
QuantHealth provides AI-powered clinical trial simulation platform that predicts patient responses to therapies. The company enables pharmaceutical sponsors to optimize protocol design, reduce trial costs, and improve success rates through virtual clinical trials using real-world data from 350M patient lives.
Reify Health
Reify Health is a clinical trials technology company that connects research sites, sponsors, patients, and other stakeholders on a unified platform. Through its OneStudyTeam platform and Care Access initiative, the company aims to accelerate clinical trial operations and expand access to trials in underserved communities.
Renalytix
Renalytix is an AI-enabled in vitro diagnostics company focused on optimizing clinical management of kidney disease.
Science 37
AI-powered clinical trial platform that accelerates patient recruitment, trial matching, and decentralized trial execution.
Signant Health
Signant Health provides comprehensive eClinical technology solutions for clinical trials, including eCOA/ePRO, EDC, RTSM, and supply chain software. The company serves pharmaceutical sponsors, CROs, and biotech firms globally, delivering clinical data collection, patient engagement, and trial management solutions backed by 30 years of experience.
SubjectWell
SubjectWell provides patient recruitment and site enablement solutions for clinical trials through its SubjectWell+ platform. The company connects sponsors, CROs, sites, and patients via a network of 15+ million patients, reducing enrollment time by 30% across 400+ therapeutic areas.
THREAD Research
THREAD provides a comprehensive clinical research platform combining eCOA technology, decentralized clinical trial (DCT) capabilities, and patient-centered outcomes research consulting. The company serves life science organizations, CROs, and research sites with end-to-end solutions for designing, operating, and scaling next-generation clinical trials.
Trial Library
Trial Library is an AI-native platform that connects patients to clinical trials by activating providers, identifying eligible patients, and navigating them through the trial lifecycle. The company serves health systems, biopharma sponsors, and payers to make clinical research a standard care option.
Trialbee
Trialbee is a global patient recruitment platform for clinical trials that delivers pre-qualified, trial-ready patients through AI-powered screening and real-time analytics. The company serves sponsors, CROs, and research sites across 50 countries with multilingual recruitment capabilities.
TriNetX
TriNetX provides a global federated network of real-world healthcare data connecting 13,000+ clinical sites across 20+ countries. The platform enables pharmaceutical companies, healthcare providers, and academic researchers to access harmonized clinical data from 300M+ patients for trial design, real-world evidence generation, and clinical research.
Triomics
AI-powered platform for optimizing clinical trial design, patient recruitment, and trial outcomes.
Unlearn.AI
Unlearn.AI uses AI to generate digital twins of clinical trial patients, enabling smaller, faster, and more efficient clinical trials.
Veeva Systems
Veeva Systems provides cloud-based software solutions for the global life sciences industry, spanning clinical trials, regulatory affairs, quality management, safety, medical affairs, and commercial operations for pharmaceutical, biotech, and MedTech companies.
Related Articles
All News →
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Preclinical studies reveal engineered vascular organoids can integrate with damaged heart tissue and restore blood flow, offering a regenerative alternative to traditional bypass surgery.

Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
A groundbreaking UK study demonstrates that early intervention with an existing drug can prevent the onset of debilitating autoimmune disease in high-risk patients, opening the door for AI-powered predictive screening.

AI-Powered Synthetic Heart Could End Animal Testing in Cardiac Device Development
Australian researchers have developed a soft robotic heart that uses artificial intelligence to replicate both healthy and diseased cardiac conditions, offering a breakthrough alternative for medical device testing.

Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.

Inside Interoception: The hidden sense of how you feel inside
This internal sensing system continuously monitors heart rate, breathing, and metabolic states—and disruptions may explain why patients feel anxious or unwell without obvious cause.

Why “reprogramming” is the buzziest approach to reversing aging right now
Cellular reprogramming uses Yamanaka factors to reset the epigenetic clock without erasing cell identity, with Life Biosciences now testing this aging reversal approach in human glaucoma patients for the first time.

Nvidia, Abridge collaborate to develop healthcare-specific AI model
The partnership aims to create a purpose-built foundation model for clinical conversations, moving beyond adapted general-purpose AI to address unique medical communication challenges.

Alphabet's AI Scans Sewage at World Cup to Predict Disease Outbreaks Before Symptoms Emerge
Verily deploys wastewater surveillance technology across World Cup host cities to detect disease outbreaks up to a week before symptoms appear in populations.

Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.